2010
DOI: 10.1590/s1516-31802010000300007
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews

Abstract: Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviewsEficácia e segurança dos antipsicóticos atípicos (quetiapina, risperidona, aripiprazol, paliperidona) ABSTRACTCONTEXT AND OBJECTIVE: According to some cohort studies, the prevalence of refractory schizophrenia (RS) is 20-40%. Our aim was to evaluate the effectiveness and safety of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0
6

Year Published

2011
2011
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 86 publications
(139 reference statements)
0
7
0
6
Order By: Relevance
“…To achieve better efficacy, blockade of both serotonin 5-HT 2A and dopamine D 2 receptors is warranted at clinically effective doses. There is now considerable preclinical and some clinical evidence that effects on 5-HT receptors contribute to the low risk of producing EPS, which is the defining characteristic of the atypical antipsychotics, compared to typical antipsychotics [84, 85]. …”
Section: Development Of Antipsychotics For the Treatment Of Schizophrmentioning
confidence: 99%
“…To achieve better efficacy, blockade of both serotonin 5-HT 2A and dopamine D 2 receptors is warranted at clinically effective doses. There is now considerable preclinical and some clinical evidence that effects on 5-HT receptors contribute to the low risk of producing EPS, which is the defining characteristic of the atypical antipsychotics, compared to typical antipsychotics [84, 85]. …”
Section: Development Of Antipsychotics For the Treatment Of Schizophrmentioning
confidence: 99%
“…Além disso, os pacientes não refratários utilizaram maior número de associações com antidepressivos e benzodiazepínicos, o que possivelmente pode ter ocorrido por causa da maior possibilidade do diagnóstico de comorbidades psiquiátricas em pacientes com esquizofrenia quando há controle adequado dos sintomas psicóticos 16 . Por outro lado, observou-se diferença estatisticamente significante entre o uso de ISRS em pacientes não refratários.…”
Section: Discussionunclassified
“…In the childhood and adolescence specialty, for example, EBP ranged from anxiety disorder, whether for treatment (18) or assessment (19) , vaccination (24)(25) , safety during nebulization (28) , ICU death (29) , physical exercise measure (33) , nutritional interventions and child growth (70) , prenatal and weight at birth (71) , among others. Another quite diversified example comes from psychiatry/mental health: medication treatments (15,18,20,76,80,89) , physical exercise (16) , cognitive therapy (17) , anxiety assessment instrument (19) , quality of life and food disorders (35) , psychological stress x hypertension (40) , family intervention in schizophrenia (50) etc.…”
Section: Discussionmentioning
confidence: 99%